Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,984 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,380
Recruiting: 746
Ph III recruiting: 80
Growth YoY: +20.9%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27%
Trials / 1,000 deaths: 40.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 401–450 of 5,984 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06842498	A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)	recruiting	Phase 2	75	Kyntra BioINDUSTRY	1	Aug 17, 2026	clinicaltrials
NCT06957691	Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy(Fezo-ADT)	recruiting	Phase 2	60	Shehzad Basaria, M.D.OTHER	1	Aug 17, 2026